Roche Czech Republic's operating cash flow stood at CZK 621 mil in 2016, up 13% when compared to the previous year. Historically, between 2003 - 2016, the firm’s operating cash flow reached a high of CZK 730 mil in 2008 and a low of CZK -420 mil in 2005.
Roche Czech Republic's total investments stood at CZK -94.9 mil and accounted for 2.30% of sales in 2016. This is compared to an average of 2.75% as seen over the last five years.
Cash from financing amounted to CZK -458 mil, so the company generated CZK 68.3 mil net cash in 2016.
At the end of 2016, the company had a net debt of CZK 203 mil, or 0.428x of EBITDA and 14.2% of equity. Net working capital amounted to CZK 1,667 mil, or 33.6% of sales. Cash conversion cycle is negative and reached 129 days days in 2016. This means Roche Czech Republic generates revenue from customers before it has to pay its suppliers for inventory, among other things.
You can see all the company’s data at Roche Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
